“Kidney disease can affect anyone, but certain groups are at higher risk,” says Dr. Louise Moist, William F. Clark chair of ...
17m
HealthDay on MSNSotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk FactorsFor patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual sodium ...
A marker of kidney antioxidant activity and a marker of fibrosis both show relationships with kidney failure risk, independent of other factors. New research links serum afamin and urinary ...
Vitamin D deficiency is independently associated with increased depression risk in patients with chronic kidney disease.
Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...
While this has been long speculated, whether chronic kidney diseases and mental health issues were connected or not, a new ...
March marks National Kidney Disease Awareness Month, a time to raise awareness about kidney health, the challenges those with kidney disease face, and the life-saving role of organ donation.
Your kidneys are the most important organs for maintaining the health of your body by expelling toxins and balancing ...
For those unaware, all funds raised will be going towards Northern Ireland Kidney Research Fund. They are the only charity in ...
Urinalysis is one of the most frequently ordered diagnostic tests, critical for identifying conditions like urinary tract infections (UTIs), kidney disease, and diabetes. However, traditional dipstick ...
EMA committee recommends marketing approval for Novartis oral Fabhalta to treat adults living with C3 glomerulopathy: Basel Monday, March 3, 2025, 10:00 Hrs [IST] Novartis announc ...
The CHMP recommends granting a marketing authorization to NVS' Fabhalta for the treatment of adults with C3 glomerulopathy, an ultra-rare, progressive kidney disease with no currently approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results